Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
US
|
Europe
|
Latin America
|
Asia Pacific
|
World
|
clinica
Regions - Asia Pacific
Mexico extends US-Canada medtech recognition to Japan
31 January 2012
Mexico’s healthcare products regulator, Cofepris, has signed with Japan an equivalency agreement allowing for the expedited review of certain medical devices. The initiative, which was announced by the health ministry on 24 January, is effectively ...
China to regulate cosmetic contact lenses as Class III devices
24 January 2012
China is to regulate non-corrective coloured contact lenses as Class III (highest-risk) medical devices. The State Food and Drug Administration is expected to issue a notice on the matter shortly, specifying the date from which these lenses may not ...
Less investment but more value for Singapore biomedical sector last year
23 January 2012
While Singapore saw a sharp fall in investment commitments in the biomedical manufacturing sector last year, these have shifted to operations and products that are expected to add more value to the economy in the future, the latest figures from the ...
Life Tech forms molecular Dx JV with China's DaAn; unveils $1,000 genome
19 January 2012
Life Technologies is strengthening its presence in China, with an agreement to set up a diagnostics joint venture with local molecular IVD specialist DaAn Gene. Financial details of the deal were not disclosed. The JV, called Life Technologies DaAn ...
PIP successor France Implant Technologie scuppered by current crisis
04 January 2012
Plans by the family of Jean-Claude Mas, founder of the now defunct French breast implants manufacturer Poly Implant Prothèse (PIP), to establish a new cosmetic implants company were scuppered by the current flare-up in the crisis surrounding the PIP ...
 
First we take Europe, then the US – the irresistible rise of China 18 January 2011

A new report on the medtech innovation potential of countries around the world confirms a long-held suspicion: the emerging markets of China and India are gaining on the US. This has been the consensus view based on informed speculation for several ...

Safety in numbers: how do medtech hotspots develop, and why? 20 September 2010

Medtech companies have a tendency to come together and flourish in certain areas. Peter Charlish examines the phenomenon, and asks why companies find that there is safety in numbers Ever since the semiconductor industry established itself in the ...

 
Japan: infrastructure for implementing companion diagnostics needed
05 January 2012
Personalised medicine holds the promise of improved, more targeted treatment for patients and companion diagnostics play a key role in this new healthcare paradigm. Dr Isao Ikeda, chairman of the AMMD's IVD Committee, provides an outline of the key ...
Clinica 100: The rise and rise of Mindray
01 December 2011
China's success may have been founded in mass manufacturing of commodity products, but the country now boasts some home-grown companies which are churning out notable innovations in their respective fields. Mindray Medical is one such concern that ...
Lessons learned from the 3/11 Great East Japan Earthquake and Tsunami
12 September 2011
Six months on after Japan was hit by the most destructive earthquake in its history, the country is still a long way off from restoring its devastated infrastructure. In this article, Takashi Shimada, vice-chairman of the American Medical Devices ...
 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
MEDICAL TECHNOLOGY


Loading MEDICAL TECHNOLOGY ....
 
EVENTS
The 14th MedTech Investing Europe conference
19 March 2012
Montreux Convention and Music Centre, Switzerland
HTAi 2012
23 June 2012
Bilbao, Spain
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm